This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vanhala, R. Articles by Riikonen, R. Search for Related Content PubMed PubMed Citation Articles by Vanhala, R. Articles by Riikonen, R. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Rett Syndrome Social Bookmarking                   What's this?

Insulin-Like Growth Factor-I in Cerebrospinal Fluid and Serum in Rett Syndrome

Unit of Child Neurology, Hospital for Children and Adolescents and the Helsinki University Central Hospital, raij-vanhala{at}huch.fi

Ursula Turpeinen, PhD

Laboratory University of Helsinki, Helsinki, Finland

Raili Riikonen, PhD

Department of Child Neurology, Children's Hospital, University of Kuopio Kuopio, Finland

Rett syndrome is a neurodevelopmental disease characterized by failure of somatic and brain growth. The insulin-like growth factor system mediates most actions of growth hormone. Evidence that it plays an important role in early development of the brain is increasing. The aim of the study reported was to assess the role of the insulin-like growth factor system in the pathogenesis of Rett syndrome. We measured insulin-like growth factor-I levels in serum (8 patients, mean age 9.1 years) and cerebrospinal fluid (13 patients, mean age 7 years) using a sensitive radioimmunoassay method and compared them with those in age-matched controls (13 and 26 patients, respectively). Neither serum nor cerebrospinal fluid insulin-like growth factor-I levels differed from those in controls. We also measured insulin-like growth factor binding protein-3 levels in serum (in 9 patients and 8 controls) and in cerebrospinal fluid (in 12 patients and 11 controls) and serum growth hormone levels (in 8 patients and 11 controls); the levels in patients did not differ from those in controls. We found no significant correlation between serum and cerebrospinal fluid insulin-like growth factor-I in Rett syndrome. This may indicate an independent role of insulin-like growth factor system in the central nervous system, making serum insulin-like growth factor-I measurement unreliable as an indicator of disturbed function in the central nervous system. Our results did not support the notion that a defective insulin-like growth factor-I system explains the lack of somatic and brain growth in Rett syndrome. (J Child Neurol 2000;15:797-802).

Journal of Child Neurology, Vol. 15, No. 12, 797-802 (2000)
DOI: 10.1177/088307380001501205


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Tropea, E. Giacometti, N. R. Wilson, C. Beard, C. McCurry, D. D. Fu, R. Flannery, R. Jaenisch, and M. Sur Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice PNAS, February 10, 2009; 106(6): 2029 - 2034. [Abstract] [Full Text] [PDF]